Manufacturer: XT Labs
Pharmaceutical name: Ipamorelin
Pack: 1 vial (10 mg)
Ipamorelin is an intriguing new discovery in muscle building that is garnering significant interest in the bodybuilding community. Similar to the GHRP-6 peptide (growth hormone releasing hexapeptide), it is a synthetic peptide with potent Growth Hormone releasing capabilities. These GH releasing abilities are particularly appealing to athletes and bodybuilders, as they can greatly influence muscle growth and fat-burning speed.
Athletes typically administer Ipamorelin in doses of 200mcg - 300mcg, two to three times a day, using a small insulin needle for injection. They often start with the lower dose to mitigate potential side effects, which can include headaches or sensations akin to a head rush. Ipamorelin can be taken at any time, but taking it approximately 30-45 minutes prior to a workout seems optimal due to the resulting surge in Growth Hormone (GH), facilitating maximum growth.
Research on the impact of Ipamorelin on bone growth, body weight, and GH release has yielded some intriguing findings.
In one study, varying doses were given over a 15-day period to observe the subjects' responses.
There was a clear and dose-dependent increase in body weight; however, the treatment group did not exhibit any changes in total IGF-I levels. Additionally, there were no significant alterations in serum markers associated with bone development. For instance, the number of cells in the broad section of the tibia (shinbone) did not vary appreciably. This is positive as it indicates muscle growth with a reduced risk of bone or cartilage deformity.
The response of the pituitary gland to a high intravenous dose of Ipamorelin indicated that plasma GH levels significantly decreased, while levels remained stable after a similar dose of GHRH. This is actually advantageous as it implies that Ipamorelin may not inhibit the body's natural GH production, further affirming that Ipamorelin is a selective GH releaser.